Golden
Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim is a pharmaceutical company.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Amr Youssef

Employee

Aaron Graham

Employee

Aashir Awan

Employee

Abbas Shivji

Employee

abdellatif ziane

Employee

Aditya Singh

Employee

Adrian van Alphen

Employee

Adriana Oreskovic

Employee

Agustina Yornet

Employee

Aisling Glennie

Employee

Alan Davis

Employee

Alan Wong

Employee

Albert Lens

Employee

Alberto Delmoral

Employee

Alceu Rodrigues de Freitas Junior

Employee

Alejandro Medici

Employee

Alejandro Piris

Employee

Alex Lincoln-Dodgson

Employee

Alex Pavlenko

Employee

Alexander Dross

Employee

SHOW MORE (381)

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
Sohini Das
March 1, 2020
@bsindia
Boehringer has expanded its field force to 570 representatives to boost their diabetes medicine sales that contributes nearly 75 per cent of the companys turnover
June 4, 2019
WebWire
, , , , • New digital disease management program "Tiba Yako" breaks access and awareness barriers in hypertension and diabetes care, , • The mobile-based technology allows patients to monitor their blood pressure and blood glucose levels at home, digitally sending the results to their doctor , , • Tiba Yako is an integrated disease service model that will offer benefits to patients, healthcare providers and payers alike , , • There is an unmet need for efficient affordable and widely accessible ca...
May 16, 2019
WebWire
Boehringer Ingelheim uses digital technologies along the entire value chain to discover the medications and healthcare solutions of the future. Collaboration with start-ups and other drivers of innovation is playing an increasingly important role, so Boehringer Ingelheim, a family-owned company, is complementing its internal expertise specifically by cooperating with external parties for research and development, production, and patient care. More than 150 cooperative projects are ongoing...
Research and Markets
Invalid Date
www.prnewswire.com:443
DUBLIN, Feb. 12, 2019 /PRNewswire/ -- The "Global Equine Healthcare Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key...